Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
The global medical devices industry is undergoing a major transformation in business models, technology adoption, and care delivery approaches, according to Frost & Sullivan's...
CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma (NTAP™) device for cancer treatment, announced today the enrollment of the first...
